13D Filing: Meridian OHC Partners Gunning for Board Seat at Infusystem Holdings, Inc (INFU)

Page 7 of 9 SEC Filing

CUSIP No. 45685K102
13D
Page 7 of 8 Pages
Item 1.  Security and Issuer.
This Schedule 13D relates to Common Stock (the “Shares”) of InfuSystem Holdings, Inc. (“INFU” or the “Company”) with its principal executive offices located at 31700 Research Park Drive Madison Heights, Michigan 48071.
Item 2.  Identity and Background.
This statement is filed on behalf of Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, LP, and BlueLine Partners, LLC (collectively, the “Reporting Entities”).  TSV Investment Partners, LLC  is the sole general partner of Meridian OHC Partners, LP and Meridian TSV II, LP and BlueLine Partners, LLC is the sole general partner of BlueLine Capital Partners II, LP.  Scott Shuda is Managing Director of TSV Investment Partners, LLC and BlueLine Partners, LLC.  Mr. Shuda disclaims beneficial ownership for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the “Act”).  The address of TSV Investment Partners, LLC is 425 Weed Street New Canaan, CT 06840and the address of BlueLine Partners, LLC is 3480 Buskirk Avenue Suite 214, Pleasant Hill, CA 94523.  During the last five years, none of the Reporting Entities has been convicted in a criminal proceeding or been a party to a civil proceeding of a judicial or administrative body.  Each of the Reporting Entities is a Delaware limited partnership or Delaware limited liability company.  Mr. Shuda is a U.S. citizen.
 Item 3.  Source or Amount of Funds or Other Consideration.
All of the funds used in making the purchase of the Shares described in Item 5 of this Schedule 13D came from the working capital of the Reporting Entities.
Item 4.  Purpose of Transaction.
The Reporting Entities have purchased the Shares for investment purposes.  The Reporting Entities have changed their filing status from that described by Schedule 13G to that described by Schedule 13D to reflect the fact that Mr. Shuda communicated to the Company on February 11, 2016 his interest in serving on the Board of Directors of the Company.  The Reporting Entities believe that the service of Mr. Shuda would benefit the Company and its shareholders, particularly in the area of examining and providing insights into the return on investment (ROI) of the Company’s expenditures in areas such as operations infrastructure, pump inventory and IT systems. The Reporting Entities believe such insights would prove helpful in the context of future decisions concerning the best allocation of INFU’s strong operating cash flows.
Item 5.  Interest in Securities of the Issuer.
As of the date of this Schedule 13D, each of the Reporting Entities may be deemed to own 2,451,972 shares of Common Stock (the “Shares”).  The Shares represent approximately 10.9% of the shares of Common Stock outstanding based on 22,514,484 shares of the Company’s Common Stock outstanding at November 5, 2015 as reported in the Company’s Form 10-Q for the Company’s fiscal quarter ended September 30, 2015 as filed with the Securities and Exchange Commission on November 12, 2015.
The Reporting Entities are making this single, joint filing because they may be deemed to constitute a “group” within the meaning of Section 13(d)(3) of the Act.  Each Reporting Entity expressly disclaims beneficial ownership of any of the shares of Common Stock other than those reported herein as being owned by it.
As of the date of this Schedule 13D, Meridian OHC Partners, LP and TSV Investment Partners, LLC collectively have shared voting power with respect to 2,340,276 Shares; Meridian TSV II, LP TSV and Investment Partners, LLC collectively have shared voting power with respect to 14,028 Shares; and BlueLine Capital Partners II, LP and BlueLine Partners, LLC collectively have shared voting power with respect to 97,688 Shares.
The Reporting Entities have not effected any transactions involving the Shares during the past sixty days.  This Schedule 13D succeeds prior statements on Schedule G filed by the Reporting Entities.  To the knowledge of the Reporting Entities, none of the executive officers or directors of TSV I or BLGP I has engaged in any transaction in any shares of the Issuer’s Common Stock during the sixty days immediately preceding the date hereof.
No person (other than the Reporting Entities) is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares that are the subject of this Schedule 13D.
Item 6.  Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
Pursuant to Rule 13d-1(k) promulgated under the Act, the Reporting Entities have entered into an agreement with respect to the joint filing of this statement, and any amendment or amendments hereto, which is attached hereto as Exhibit A.
Item 7.  Material to Be Filed as Exhibits.

Follow Infusystem Holdings Inc (NYSEMKT:INFU)